D-Wave Quantum Inc. (NYSE: QBTS)

The QualityStocks Daily Newsletter would like to spotlight D-Wave Quantum Inc. (NYSE: QBTS).

D-Wave Quantum Inc. (NYSE: QBTS) ("D-Wave") formed a new business unit dedicated to driving the adoption of its quantum computing products and services within the U.S. government. Led by seasoned government and public sector business executive Jack Sears Jr., the newly established unit will support D-Wave's enterprise-wide U.S. government-related initiative. Sears will join D-Wave's executive team and serve as the business unit's vice president of U.S. government solutions. In his role, Sears will oversee government-related go-to-market efforts and application development as well as the unique product development and customer support necessary for secure systems that meet federal requirements. He brings more than 25 years of experience in developing and executing organizational growth strategies for companies serving the federal government in the defense and aerospace industries.

To view the full press release, visit https://ibn.fm/V6heJ

Quantum technology is moving from distant theory to something businesses and the public are starting to pay attention to. A new study called the Quantum Index Report 2025 shows how interest in quantum computing is growing, even though many people still do not fully understand it. The report looks at how companies talk about quantum computing and how everyday people view the technology. Together, these findings paint a clear picture of where quantum stands today and where it may be heading. The report also notes that quantum technology itself is still developing. Issues like error correction, qubit stability, and hardware performance need further improvement before quantum systems can be widely used. Even so, the growing interest from both the business world and the public indicates that the path toward real-world quantum applications is becoming more visible. As companies continue to explore this new technology, awareness and understanding are likely to grow as well. Entities like D-Wave Quantum Inc. (NYSE: QBTS) that are at the forefront of efforts to commercialize cutting-edge quantum computing solutions can look at this increasing interest in the industry as an indicator of the potential of this technology to transform not just computing but also many industries. 

D-Wave Quantum Inc. (NYSE: QBTS) is a leader in quantum computing systems, software and services focused on delivering customer value via practical quantum applications for problems such as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection and financial modeling. As the only provider building both annealing and gate-model quantum computers, the company is unlocking commercial use cases in optimization today, while building the technologies that will enable new solutions tomorrow.

D-Wave is a pioneer in quantum computing, with a history of delivering the world’s first commercial quantum computer; the first real-time quantum cloud service; countless hardware and software product and research milestones; and the planned first cross-platform quantum solution which will deliver both annealing and gate-model quantum computers to customers via an integrated platform. Its current commercial product offerings include: Advantage™ (fifth generation quantum computer), Leap™ (quantum cloud service), Launch™ (quantum computing onboarding service) and Ocean™ (full suite of open-source programming tools).

D-Wave’s relentless pursuit of practical quantum computing has resulted in the technology being used today by some of the world’s most advanced enterprises – more than 25 of the Forbes Global 2000 use D-Wave.

D-Wave’s commercial customers include blue-chip industry leaders like Volkswagen, Accenture, BBVA, NEC Corporation, Save-On-Foods, DENSO and Lockheed Martin. The company boasts an extensive IP portfolio featuring more than 200 issued U.S. patents and over 100 peer-reviewed papers published in leading scientific journals.

Founded in 1999, D-Wave is the world’s first commercial supplier of quantum computers. With headquarters and the Quantum Engineering Center of Excellence based near Vancouver, Canada, D-Wave’s U.S. operations are based in Palo Alto, California.

Advantage™ Quantum Computer

 

With the Advantage™ Quantum Computer, D-Wave has incorporated two decades of experience and over 10 years of customer feedback to create the first and only quantum computer designed for business. The platform features a new processor architecture with over 5,000 qubits and 15-way qubit connectivity. This is 2.5x more connections and more than double the number of qubits than the company’s previous generation quantum computer.

D-Wave’s quantum computers, first located in its facilities in British Columbia, have been available to North American users through its Leap™ quantum cloud service since 2018. It has since introduced new Advantage systems in Julich, Germany, and most recently, Marina Del Rey, California, which marked the availability of the first Advantage quantum computer physically located in the United States.

That new deployment is part of the USC-Lockheed Martin Quantum Computing Center (QCC) hosted at USC’s Information Sciences Institute (ISI), a unit of the University of Southern California’s prestigious Viterbi School of Engineering. Additionally, Amazon Web Services (AWS) and D-Wave announced that the U.S.-based system is available for use in Amazon 2racket, expanding the number to three different D-Wave quantum systems available to AWS users.

Leap Quantum Cloud Service

 

D-Wave’s customers interface with its systems through the Leap™ quantum cloud service. Leap delivers immediate, real-time access to the company’s Advantage quantum computer and quantum hybrid solver service, all with enterprise-class performance and scalability.

Leap allows developers proficient in Python to get started building and running quantum applications. Through a seamless and secure cloud-based connection, users can easily start solving complex problems of up to 1 million variables and 100,000 constraints.

Using Leap, D-Wave customers have developed quantum hybrid applications for use cases in manufacturing, logistics, financial services, life sciences, materials science, retail and transportation. By eliminating the need to wait hours, days or weeks to get good answers to a broad array of problems, D-Wave is helping businesses move forward.

D-Wave Launch

D-Wave Launch™ is the company’s onboarding platform aimed at helping businesses easily start their quantum journey. Through this program, D-Wave’s team of experts and partners aid enterprises in identifying best use cases for quantum and work with them to develop a proof of concept and production pilot.

From there, the team coordinates with customers to get their hybrid quantum applications up and running, providing ongoing Leap quantum cloud access to ensure the application is operating smoothly and delivering real business value.

Target Verticals

While the potential applications for quantum computing are effectively limitless, D-Wave has identified a number of industry verticals as key areas of focus for its quantum architecture, providing case studies for each. These include:

• Manufacturing – D-Wave worked with Volkswagen to identify a commercial optimization application, the binary paint shop problem, which was run on D-Wave’s hybrid solver service. The solver outperformed four purely classical methods on problem sizes at commercial scale (N=3,000). In a separate project, similar inputs were tested using a leading ion trap system, which failed to find any commercial solution.
• Life Sciences – Menten AI makes use of D-Wave quantum computing to assist in the design of novel therapeutic peptides—short strings of amino acids that can act as potent drugs. With the rise of COVID-19, D-Wave’s Advantage system made it possible to identify molecules that might be especially well-suited for binding and inhibiting the related spike protein, producing several promising peptide designs.
• Finance – Multiverse Computing, a leader in developing quantum solutions for the financial sector, leveraged D-Wave’s hybrid solver service in a collaboration with BBVA, one of the world’s largest financial institutions. Multiverse demonstrated management strategies that far exceeded the granularity of traditional returns in a fraction of the time, helping BBVA identify a low-risk portfolio for investment.

Market Opportunity

The quantum computing total addressable market is projected to grow between $450 billion and $850 billion over the next 15 to 30 years, with between $5 billion and $10 billion of anticipated TAM growth coming in the next three to five years, according to Boston Consulting Group. Driving factors behind this growth include rising investments in quantum computing tech by governments and an increasing number of commercial use-cases.

Forward-thinking organizations see quantum as an opportunity to move ahead of the competition. From finding efficiencies and reducing waste to decreasing time to solution and solving problems abandoned due to complexity, the business value is real. According to data from 451 Research, 40% of large enterprises are already experimenting with quantum computing.

D-Wave is strategically positioned – in an industry with significant barriers to entry – as evident by a decades-long track record serving a roster of blue-chip customers. The company is singularly focused on helping its customers achieve clear value by leveraging quantum computing in practical business applications. With a full stack of systems, software, developer tools and services, D-Wave is working to enable enterprises, governments, developers and researchers to access the power of quantum computing, thereby providing an intriguing opportunity for prospective investors.

D-Wave’s current investor base includes PSP Investments, Goldman Sachs, BDC Capital, NEC Corporation, Aegis Group Partners and In-Q-Tel.

Leadership Team

Dr. Alan Baratz has served as the CEO of D-Wave since 2020. Previously, as Executive Vice President of R&D and Chief Product Officer, he drove the development, delivery, and support of all of D-Wave’s products, technologies, and applications. Dr. Baratz has over 25 years of experience in product development and bringing new products to market at leading technology companies and software startups. As the first president of JavaSoft at Sun Microsystems, he oversaw the growth and adoption of the Java platform from its infancy to a robust platform supporting mission-critical applications in nearly 80 percent of Fortune 1000 companies. He has also held executive positions at Symphony, Avaya, Cisco, and IBM. Dr. Baratz holds a doctorate in computer science from the Massachusetts Institute of Technology.

John Markovich is the company’s CFO. He brings to D-Wave over three decades of experience working with rapidly growing private and public technology companies across all stages of development. Mr. Markovich has directed the finance, accounting, tax, treasury, M&A, legal, operations, customer service, IR, HR, and IT functions for companies ranging from privately held pre-revenue startups to an NYSE-listed Fortune 500 multi-national company with over $1.2 billion in annual revenue. During his career, he has negotiated and closed over 150 debt, equity, M&A, and joint venture transactions exceeding $2.5 billion in value; over a dozen private placements; nearly a dozen M&A transactions; and several international joint ventures. Mr. Markovich holds a BS in Business from Miami University and an MBA from the Michigan State Graduate School of Business.

D-Wave Quantum Inc. (NYSE: QBTS), closed Wednesday's trading session at $25.08, up 11.4667%, on 39,960,591 volume. The average volume for the last 3 months is 35,576,406 and the stock's 52-week low/high is $2.88/$46.75.

Recent News

• D-Wave Quantum Inc. (NYSE: QBTS) - Quantum Report Provides Insights on Public Awareness, Business Interest
• TechMediaBreaks - D-Wave Quantum Inc. (NYSE: QBTS) Forms U.S. Government Business Unit Led by Jack Sears Jr.
• New Lab Facilitates GenAI Wargaming for Defense Purposes

SuperCom Ltd. (NASDAQ: SPCB)

The QualityStocks Daily Newsletter would like to spotlight SuperCom Ltd. (NASDAQ: SPCB).

The company has won its first U.S. state-level Department of Corrections contract, securing a statewide deployment in Arizona.

The Arizona agreement displaces an incumbent provider and follows SuperCom's expansion strategy toward higher-volume, longer-term DOC-level programs.

Days earlier, the company entered Missouri with a new electronic-monitoring contract, its 13th state entry since mid-2024.

SuperCom's PureSecurity platform continues to replace long-time incumbents across multiple jurisdictions.

The company reports record profitability, with $6 million in net income and gross margins above 60% through the first nine months of 2025.

SuperCom (NASDAQ: SPCB) , a global provider of secured e-Government, IoT, and cybersecurity solutions, has secured its first state-level Department of Corrections contract in the United States, marking a new stage in its U.S. expansion. The contract, awarded under Arizona's statewide Behavioral Health services program, will deploy the company's GPS-based PureSecurity technology as part of broader rehabilitative and supervision services. Implementation is scheduled to begin in January 2026, according to the company's announcement ( https://ibn.fm/yK21N ).

SuperCom Ltd. (NASDAQ: SPCB) is a global provider of secure solutions spanning electronic monitoring, e-Government, and cybersecurity markets. Since 1988, the company has supported national governments and public agencies with advanced safety, identity, and tracking technologies. Its solutions enable courts, service providers, and public safety agencies to efficiently supervise high-risk populations, improve victims’ safety and manage compliance with judicial mandates across multiple jurisdictions.

SuperCom’s growth in North America has accelerated since mid-2024, with expansion into 11 new U.S. states and more than 30 contracts secured with public safety agencies and regional service providers, displacing long-standing incumbents in the process. This expansion reflects the company’s emphasis on recurring revenue, technological differentiation, and close partnership with agencies seeking innovative, mobile-first alternatives to outdated systems.

SuperCom’s vision is to revolutionize the public safety sector through proprietary electronic monitoring technology, data intelligence, and flawless execution. Its offerings include GPS and RF-based monitoring, biometric ID verification, mobile law enforcement tools, and national-level e-ID platforms.

The company is headquartered in Tel Aviv, Israel.

Products

Electronic Monitoring and Public Safety

SuperCom’s operations are anchored by its proprietary PureSecurity™ suite, a unified offender monitoring platform combining GPS tracking, biometric verification, tamper detection, and advanced data analytics. Its PureOne™ one-piece bracelet and PureTrack™ smartphone-integrated solution offer high-precision location tracking, real-time alerts, and seamless integration with PureCom™ base stations, PureBeacon™ indoor trackers, and PureProtect™, an app designed to safeguard domestic violence victims.

The company complements its hardware with PureMonitor™, a secure, cloud-based case management system that enables real-time oversight, mobile access, and data visualization for monitoring agencies. This full-stack approach allows SuperCom to support a range of court-mandated programs including GPS monitoring, house arrest, curfew enforcement, and community supervision. The company’s domestic violence monitoring solutions are now deployed in at least seven countries.

SuperCom’s U.S. subsidiary, Leaders in Community Alternatives (LCA), provides reentry and rehabilitation services that complement the company’s electronic monitoring programs. Operating primarily in California, LCA delivers community-based solutions designed to reduce recidivism and promote successful reintegration. Its programs include individualized case management, employment support, evidence-based treatment, and day reporting centers—services that support public safety while offering alternatives to incarceration. Since LCA’s acquisition in 2016, SuperCom secured over $35 million in new contract wins in Northern California.

Cybersecurity

SuperCom also offers additional capabilities through its cybersecurity and e-Government product lines. The company’s cybersecurity subsidiary, Safend Ltd., provides endpoint data protection through its Data Protection Suite. This platform includes modules for encryption (Encryptor), port/device control (Protector), data classification (Discoverer), DLP (Inspector), audit tracking (Auditor), and compliance reporting (Reporter).

e-Gov

Through proprietary e-government platforms and innovative solutions for traditional and biometrics enrollment, personalization, issuance, and border control services, SuperCom has helped governments and national agencies design and issue secured multi-identification documents and robust digital identity solutions to their citizens, visitors, and lands. The company has focused on expanding its activities, including the design, development, and marketing of identification technologies and solutions to governments in Europe, Asia, America, and Africa using SuperCom’s e-Government platforms.

Market Opportunity

SuperCom operates across multiple high-growth sectors. In electronic monitoring, rising incarceration costs, overcrowded prisons, and increased judicial adoption of alternatives to detention continue to drive demand for GPS and RF-based supervision programs. The company’s rapid expansion into 11 U.S. states and multiple national-level deployments in Europe and the EMEA region reflect a robust and growing market. According to Mordor Intelligence, the electronic offender monitoring solutions market size stands at $2.18 billion in 2025 and is projected to reach $3.19 billion by 2030.

SuperCom also addresses two important supplementary markets through its cybersecurity and e-Government offerings. In cybersecurity, growing threats to sensitive government and enterprise data are fueling investments in endpoint protection, compliance, and device control, which are areas directly served by the company’s Safend platform. In the public sector identity space, secure ID, biometric verification, and e-passport programs remain foundational to digital governance. SuperCom’s track record of delivering national ID solutions across Africa, Latin America, and Eastern Europe underscores its continued relevance in these adjacent sectors.

Leadership Team

Ordan Trabelsi is President and CEO of SuperCom. He has over 15 years of experience as CEO, growing high-tech companies globally. He also has experience in research and development and product innovation, as well as hands-on experience in cybersecurity, encryption, advanced mathematics, and mobile and internet network technologies. Prior to joining SuperCom, he served as co-founder and CEO of Klikot Inc., a global social networking company. He holds an MBA from Columbia University and a B.Sc. in Computer Engineering from The Technion: Israel Institute of Technology.

Barak Trabelsi is COO of SuperCom. He has expertise in big data, cyber, mobile, and internet network technologies, as well as extensive experience in product development and strategies. Prior to joining SuperCom, he served as Senior Product Manager at Equinox Ltd. Before that, he served for four years as VP of R&D at Sigma Wave, a wireless, security, and internet-focused company. He holds a B.Sc. in Computer Science and Business, as well as an MBA from Tel Aviv University.

SuperCom Ltd. (NASDAQ: SPCB), closed Wednesday's trading session at $9.315, up 2.5881%, on 40,941 volume. The average volume for the last 3 months is 95,270 and the stock's 52-week low/high is $3.08/$18.95.

Recent News

• SuperCom Ltd. (NASDAQ: SPCB) - SuperCom Ltd. (NASDAQ: SPCB) Secures First State-Level U.S. DOC Contract as It Continues Implementing Expansion Strategy
• TechMediaBreaks - SuperCom Ltd. (NASDAQ: SPCB) Secures First State-Level DOC Contract in Arizona Through Strategic Partnership
• SuperCom Ltd. (NASDAQ: SPCB) Posts Record Nine-Month Net Income as Electronic Monitoring Contracts Accelerate Across Global Markets

A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ)

The QualityStocks Daily Newsletter would like to spotlight A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ).

A2Z Cust2Mate Solutions specializes in creating, commercializing smart-cart solutions for grocery stores, supermarkets and other retail formats.

The company's mission is to "unlock the full potential of every in-store shopping journey, through digitalization and personalization."

Cust2Mate supports a digital in-store experience that closely bridges online and brick-and-mortar shopping.

From checkout lanes to connected carts, the retail experience is being reinvented — and A2Z Cust2Mate Solutions (NASDAQ: AZ ) is at the forefront of the movement. A2Z develops and deploys "smart-cart" technology that aims to transform how consumers shop in physical stores by melding convenience, personalization and data intelligence into the traditional grocery-store cart.

A2Z Cust2Mate Solutions (NASDAQ: AZ) , a global smart retail technology company, said it entered an agreement with a premium grocery retailer operating more than 50 stores in Central America to deploy the A2Z Cust2mate smart cart platform. Initial rollout is planned for early 2026 in two flagship locations, with the shared goal of expanding to a full chain-wide deployment following successful implementation. The Company said the agreement marks a significant milestone for large-scale smart cart adoption in Central America, supported by its regional channel partner Trixo, and will help redefine the in-store experience, enhance retail media opportunities, and generate new data insights. CEO Gadi Graus said the collaboration represents a major leap for smart retail in the region and sets the stage for scalable adoption across the entire chain.

To view the full press release, visit https://ibn.fm/hojss

A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) is a global retail technology company focused on redefining how consumers and retailers interact in physical store environments. Through its innovative smart cart platform, the company offers a powerful vehicle for in-store digital engagement and monetization. A2Z’s business model blends hardware, software, retail media and data services to deliver scalable, recurring revenue across multiple layers of the retail value chain.

With a clear vision to unlock the full potential of every in-store shopping journey, A2Z is committed to bridging the gap between digital convenience and physical retail. Its mission centers on transforming routine trips into dynamic experiences that benefit both shoppers and retailers by enhancing satisfaction, loyalty, and operational performance. The company’s growth is supported by strategic deployments, long-term commercial agreements, and a global footprint spanning four continents.

A2Z Cust2Mate is headquartered in Canada, Israel and the United States.

Products

A2Z Cust2Mate’s flagship offering is its smart shopping cart platform, designed to bring the benefits of e-commerce into the brick-and-mortar environment. The Cust2Mate smart cart allows shoppers to scan products, receive personalized offers, and pay directly through the cart—bypassing traditional checkout lines entirely. The system integrates real-time product search, allergen warnings, nutritional data, and location-based promotions, creating a frictionless and engaging shopping experience.

For retailers, the smart cart addresses key pain points such as theft reduction, labor optimization, and shopper engagement at the point of purchase. It provides actionable, data-driven insights that improve operational efficiency and merchandising strategies. Recent commercial results have shown increases of over 15% in purchases per shopper, strong satisfaction ratings, and 75% customer return rates. The platform also supports queue management, loyalty integration, and screen-based advertising, with the ability to retrofit legacy carts using detachable modular control panels.

The company’s operations follow a hybrid revenue model including outright purchases, SaaS-based subscriptions, and recurring fees tied to software, support, and media monetization. Carts are manufactured through Tier 1 contract manufacturers, and scalable financing solutions are in place to support ongoing growth.

In October 2025, the company launched an AI and Business Insights Division to advance artificial intelligence integration across its smart-cart ecosystem. The initiative focuses on generative-AI-powered personalization, retail-media targeting, fraud detection, product recognition, and store optimization, further strengthening A2Z Cust2Mate’s leadership in data-driven retail innovation.

Market Opportunity

A2Z Cust2Mate operates in a rapidly expanding market for smart shopping cart solutions and in-store retail media. According to 360i Research, the global smart shopping cart market is forecast to grow from $2.2 billion in 2024 to $9.7 billion by 2030, representing a 27% CAGR. Simultaneously, the retail-media sector, driven by targeted, point-of-sale advertising, is projected to reach $165 billion by 2025, reflecting an approximate 20% compound annual growth rate.

The company’s monetization strategy is well-aligned with these trends. Under its 2025 agreement with Yochananof, A2Z Cust2Mate gained exclusive rights to monetize digital assets, retail media, and behavioral data generated by its deployed smart carts. Building on that foundation, the company secured multi-year retail-media agreements with Toys “R” Us Israel, The Red Pirate, and Lego, extending advertising campaigns across up to 5,000 smart carts. These partnerships combine cost-per-thousand (CPM) advertising with commission-based revenue on completed transactions, providing guaranteed recurring income and validating Cust2Mate’s model as a retail-media and data-monetization platform for global brands.

Additionally, A2Z aims to unlock new revenue streams through a digital cart marketplace, enabling sponsored product placements, third-party app integrations, and basket-based upsells. These capabilities extend the smart cart’s value proposition beyond hardware into data, advertising, and digital commerce, supporting the company’s long-term vision for platform-based growth.

Leadership Team

Bentsur Joseph, Chairman, is a serial entrepreneur with a strong track record in building and expanding successful corporations. He previously served as Chairman of Elad Hotels (part of the Tshuva Group, one of Israel’s largest conglomerates) and held a director position at MARLAZ, a public holding company involved in industrial, real estate, communication, and high-tech sectors. Earlier in his career, he was Operations Manager at Comfy Interactive Movies, a leading publicly traded edutainment company.

Gadi Graus, CEO, brings over 30 years of multidisciplinary business expertise and a proven track record of global leadership. He has deep corporate and commercial experience across international and cross-border practices, supporting high-tech, industrial, and manufacturing firms from startup to multinational levels.

Elkana Porag, Deputy CEO and CTO, has more than 30 years of experience in technology and strategic consulting. He has held senior roles in tech strategy, architecture, and CTO leadership across Fortune 500 companies, global enterprises, and startups. Known for delivering impactful results and navigating complex organizational dynamics, he is highly regarded for his ability to transform innovative technologies into competitive business solutions.

Alan Rootenberg, CFO and Director, is a Chartered Professional Accountant with significant experience as CFO of publicly traded companies on the TSX, TSX Venture Exchange, OTCBB, and CSE. His sector expertise spans mineral exploration, mining, technology, and cannabis. He holds a Bachelor of Commerce from the University of the Witwatersrand in Johannesburg, South Africa, and earned his CPA designation in Ontario, Canada.

A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ), closed Wednesday's trading session at $6.58, up 0.9202454%, on 418,048 volume. The average volume for the last 3 months is 455,025 and the stock's 52-week low/high is $4.9975/$12.36.

Recent News

• A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) - TechMediaBreaks - A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) Reaches Agreement With Major Central American Grocer to Deploy Smart Cart Platform
• A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) Leading Charge in Retail's Smart-Cart Revolution
• TechMediaBreaks - A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) Secures $30 Million Order from Super Sapir for 3,000 Smart Carts

Safe Pro Group Inc. (NASDAQ: SPAI)

The QualityStocks Daily Newsletter would like to spotlight Safe Pro Group Inc. (NASDAQ: SPAI).

Safe Pro Group (NASDAQ: SPAI) , a mission-driven provider of AI-powered defense and security solutions, is aligned with a major federal shift as the War Department moves to acquire roughly 300,000 low-cost drones under President Trump's "Unleashing American Drone Dominance" initiative. The department's new request for information outlines a $1 billion procurement program beginning in early 2026 that will fund four production "gauntlets," starting with 12 vendors delivering 30,000 drones at $5,000 per unit and scaling toward 150,000 units at reduced costs. Secretary of War Pete Hegseth said the program aims to rebuild U.S. industrial capacity, integrate unmanned systems into all combat training, and ensure the military can field inexpensive battlefield drones at scale—tens of thousands in 2026 and hundreds of thousands by 2027. Safe Pro Group's drone-agnostic, AI-powered threat-detection computer vision technology positions the company to benefit from the War Department's expanding focus on unmanned systems, as a rapid increase in drone deployment will sharply accelerate demand for advanced imagery analysis. Its patented SpotlightAI platform has processed more than 2.26 million battlefield images and can identify over 150 types of mines and unexploded ordnance, delivering a field-proven capability directly aligned with federal priorities in unmanned intelligence, force protection, and scalable drone operations. As an American-made AI solution, Safe Pro further aligns with government efforts to strengthen domestic supply chains and advance next-generation AI and drone technologies, supporting potential deployment across military, humanitarian, and public safety missions.

Safe Pro Group Inc. (NASDAQ: SPAI) is a mission-driven technology company delivering advanced AI-powered security and defense solutions. It is focused on serving customers in the defense, homeland security, humanitarian, law enforcement, and commercial markets where its AI, drone-based services and ballistic protective gear can synergistically deliver safety and operational efficiency.

At the heart of Safe Pro’s mission is its patented artificial intelligence (AI), machine learning (ML), deep learning and applied computer vision software technology. These tools are currently being used to rapidly detect small objects in drone-based video and imagery such as landmines and unexploded ordnance (UXO), enabling safer and more efficient field operations across global conflict and post-conflict zones and supporting efforts to improve the reliability of critical infrastructure. The company’s vision is to lead the evolution of security and threat detection through AI innovation, while its mission is to empower governments, enterprises, and humanitarian organizations with tools to respond to evolving threats at scale.

With a team of leaders and subject matter experts drawn from the defense, technology, and public safety sectors, Safe Pro Group delivers U.S.-developed next-generation AI and drone services through its Safe Pro AI and Airborne Response units and high-performance, American-made ballistic protective solutions through its Safe-Pro USA subsidiary.

The company is headquartered in Aventura, Florida.

Products

Safe Pro Group’s three business units operate across software, hardware, and field services to deliver a comprehensive suite of solutions. Each division plays a distinct role in supporting defense, humanitarian and public safety missions around the world.

Safe Pro AI

Safe Pro AI’s core AI-powered computer vision technology enables the rapid analysis of drone-based imagery to autonomously detect objects of interest. Its flagship product, SpotlightAI™ can detect and label over 150 types of explosive threats including landmines, cluster munitions, and unexploded ordnance (UXO). Built on more than two years of real-world usage in Ukraine and now including additional imagery being gathered from the Asian-Pacific region and Africa, SpotlightAI™ rapidly processes and creates high-resolution maps supported by the hyper scalability of the Amazon Web Services (AWS) cloud or detects threats in real-time locally through its OnSite Windows-based software application. Today, the platform boasts one of the world’s largest datasets built on over 1.6 million real-world battlefield images from Ukraine, identifying 28,000+ threats across more than 6,750 hectares, an area equivalent in size to Manhattan.

Airborne Response

Airborne Response is a leading provider of mission critical drone services using U.S. Government-compliant small uncrewed aircraft systems (sUAS) (drones). It serves enterprises in utilities & telecom and insurance with a full-range of drone-based critical infrastructure inspection and monitoring solutions as well as Drone-as-a-First Responder (DFR) services for law enforcement and public safety. It provides customers with actionable intelligence though data capture, analytics and processing powered by AI.

Safe-Pro USA

Safe-Pro USA manufactures ultra-premium, American-made ballistic protection systems including advanced body armor and ballistic plates as well as complete Explosive Ordnance Disposal (EOD) suits, demining aprons, and bomb blankets. All products exceed U.S. and NATO standards and are designed, engineered, and produced in the U.S., supporting customers across military, humanitarian, and law enforcement sectors.

Market Opportunity

Harnessing its patented, real-time, AI-powered processing of drone-based imagery, Safe Pro is creating a uniquely powerful ‘Next-Gen’ approach to situational awareness supporting ground-based personnel in safely completing their defense/military, humanitarian, law enforcement & commercial missions.

The global threat posed by landmines and UXO spans nearly 60 countries, affecting millions of civilians and imposing significant economic burdens, particularly in agriculture and infrastructure. In Ukraine alone, the contamination of 17 million hectares has resulted in $50+ billion in agricultural losses, with World Bank estimates projecting $30 billion needed in demining costs. According to the Landmine Monitor 2024, regions in Asia, Africa, and Latin America continue to report high casualty rates.

Safe Pro is positioned to capture a portion of the $15 billion+ global defense tech market, especially in AI-driven battlefield intelligence, drone surveillance, and threat detection. As a U.S.-based AI and defense technology provider with a HUBZone-certified manufacturing arm, Safe Pro is eligible for federal and state procurement programs, public safety grants, and critical infrastructure contracts, as well as global humanitarian demining efforts.

Leadership Team

Dan Erdberg, Chairman and CEO, brings over 20 years of experience as a C-level technology executive. He has led multiple Nasdaq listings in the drone, 5G, and satellite communications sectors, raised over $50 million in growth capital, and spearheaded Safe Pro Group’s corporate strategy and acquisitions.

Theresa Carlise, Chief Financial Officer, has more than 30 years of experience in financial leadership roles for public companies. Her expertise includes equity transactions, strategic planning, and financial restructuring. She served as Chief Financial Officer, Secretary, Treasurer and Director of various publicly traded companies within the retail, telecommunications, distribution, transportation, mortgage banking and construction sectors.

Pravin Borkar, CTO and Director (President, Safe-Pro USA), has over 30 years of experience in the engineering and manufacturing of ballistic protection systems for the U.S. Department of Defense. He has developed armor solutions for personnel and aircraft platforms including the CH-53 and Blackhawk.

Christopher Todd, President (Airborne Response), is a drone industry veteran and Certified Emergency Manager (CEM®) with more than 30 years of experience. He founded Airborne Response and is President of AUVSI Florida, with expertise in public safety drone deployment and emergency response.

Safe Pro Group Inc. (NASDAQ: SPAI), closed Wednesday's trading session at $5.11, up 4.0733%, on 52,484 volume. The average volume for the last 3 months is 194,430 and the stock's 52-week low/high is $1.47/$9.1599.

Recent News

• Safe Pro Group Inc. (NASDAQ: SPAI) - DefenseNewsBreaks - Safe Pro Group Inc. (NASDAQ: SPAI) Positioned for Growth as War Department Launches Billion-Dollar Push for U.S. Drone Dominance
• Safe Pro Group Inc. (NASDAQ: SPAI) Provides Operational Update to Highlight Business Progress After Securing Over $20 Million in Strategic Investments
• TechMediaBreaks - Safe Pro Group Inc. (NASDAQ: SPAI) To Meet Investors at Upcoming Virtual Conferences

Safe and Green Holdings Corp. (NASDAQ: SGBX)

The QualityStocks Daily Newsletter would like to spotlight Safe and Green Holdings Corp. (NASDAQ: SGBX).

The energy company plans to begin servicing its own wells and market rigs and service equipment to third-party operators.

CEO Michael McLaren says the operational restart of the Oil and Gas ("O&G") service division will reduce maintenance and workover costs.

Olenox's proprietary downhole technologies, including plasma pulse and ultrasonic cleaning tools, will play a central role in the expanded service offering.

Safe & Green expects to reach cash-flow positivity in 2026, supported in part by recurring revenue from third-party well services.

The company's energy strategy aligns with ongoing U.S. policy goals focused on strengthening domestic energy production and operational independence.

Safe & Green Holdings (NASDAQ: SGBX) , a diversified holding company, said its energy subsidiary Olenox Corp. has received its U.S. Department of Transportation ("DOT") number and is preparing to mobilize its service division assets. The approval marks a procedural but necessary step for the company as it restarts its oilfield services operations and expands service capacity across its portfolio of wells ( https://ibn.fm/Ncnk5 ).

Safe and Green Holdings Corp. (NASDAQ: SGBX) is a diversified holding company focused on delivering innovative solutions across infrastructure, construction, energy, healthcare, and environmental sectors. Originally established in 2007 as SG Blocks, the company has evolved into a vertically integrated platform serving both public and private sector clients with modular, sustainable systems. Its operations span a range of industries unified by a commitment to efficient, scalable design and sustainability-driven development.

The company’s model centers on the production and deployment of prefabricated modular structures, energy systems, and infrastructure technologies, leveraging vertical integration and cross-sector synergies to support government agencies, medical networks, developers, and commercial enterprises. Safe and Green’s subsidiaries operate collaboratively to generate multiple revenue streams while pursuing opportunities in both traditional and next-generation infrastructure.

Safe and Green Holdings Corp. is headquartered in Miami, Florida.

Portfolio

SG Echo Manufacturing

SG Echo is the modular manufacturing arm of Safe and Green Holdings Corp., delivering prefabricated structures built from steel, wood, and repurposed shipping containers. As a Made-in-America manufacturer, SG Echo combines industry-leading machinery and skilled labor to execute modular projects for clients across the U.S. and globally. The company holds an ESR certification from the International Code Council for repurposed containers, enabling faster approvals and widespread applicability in commercial and industrial construction.

With the ability to reduce construction time by up to 50% and cut costs by 10–20%, SG Echo’s manufacturing process emphasizes speed, sustainability, and resilience. In October 2025, SG Echo’s operations were consolidated into a new facility in Conroe, Texas, where they now operate alongside Olenox Corp., a Safe and Green subsidiary focused on oil and gas operations, to streamline logistics and integrate manufacturing with field operations. Revenue is also generated through third-party property leasing at the Conroe site.

SG Modular Medical

SG Modular Medical designs and deploys modular point-of-care solutions tailored for the evolving demands of healthcare infrastructure. The system enables clinics and labs to be rapidly assembled from clinical, administrative, and diagnostic modules, offering adaptability based on local needs and population shifts. This modular approach is positioned as a lower-emission alternative to traditional medical construction, helping reduce the substantial carbon footprint associated with healthcare infrastructure.

Notable deployments include COVID-19 testing pods at Los Angeles International Airport (LAX), designed and delivered in partnership with airport authorities. Another initiative, launched with The Peoples Healthcare and Teamsters Local 848, involves delivering modular clinics to serve union members with onsite, high-quality care staffed by a top-tier clinical operator.

SG Development Corp.

SG DevCorp is the real estate development division of Safe and Green Holdings Corp., focused on building modular single- and multifamily projects across various income levels. The company pursues strong, green developments supported by vertically integrated manufacturing from SG Echo. SG DevCorp has stated development targets of more than 4,000 modular units totaling over 3.2 million square feet across 1,000+ acres of acquired land—a construction pipeline valued at approximately $765 million.

The division prioritizes sustainability throughout the lifecycle of its developments, reducing construction waste, energy usage, emissions, and noise pollution. Its projects aim to minimize the environmental impact while enhancing speed-to-market and structural resilience.

SG Environmental Solutions

SG Environmental Solutions provides modular environmental infrastructure and sustainable waste management technologies. At the core of this division is Sanitec, a patented system designed for medical waste sterilization and volume reduction. The technology helps organizations reduce their environmental impact while significantly lowering operational costs.

The company emphasizes responsible construction and stewardship through upcycling, waste reduction, and adaptable modular deployments. Its container-based platforms are built for diverse use cases across commercial, residential, industrial, and environmental applications, with a focus on high-efficiency, reduced-emission outcomes.

Olenox Energy

Olenox Energy is the energy development arm of Safe and Green Holdings, focused on acquiring and revitalizing distressed oil and gas assets. In May 2025, the company acquired 1,600 acres of wells and leases from Sherman Oil & Gas and its affiliates, adding 111 wells to the Olenox portfolio. Since the acquisition, Olenox has produced over 3,000 barrels of oil and is currently achieving peak production rates of 55 barrels per day. The company is preparing additional workovers to add 25–30 bpd and has completed full asset mobilization into Texas. Olenox also holds a 51% stake in Winchester Oil & Gas, representing more than 500 wells across the state.

The company is executing its strategy to build a fully integrated oil and gas platform. Olenox operations remain in full compliance with the Texas Railroad Commission, with a stated emphasis on environmental stewardship and reduced lease operating expenses.

In September 2025, Safe and Green entered into an Open Collaborative Framework with OneQode, a global digital infrastructure company. The agreement supports joint development of spill detection, real-time telemetry, and command systems for remote energy assets, enhancing Olenox’s operational capabilities through automation and data infrastructure.

Market Opportunity

Safe and Green Holdings is positioned to capitalize on macro trends across multiple sectors. The construction and real estate industries continue to seek faster, greener alternatives to traditional building methods—needs that SG Echo and SG DevCorp address through prefabricated, modular designs. In healthcare, rising demand for scalable care infrastructure underscores the relevance of SG Modular Medical’s point-of-care solutions.

Within energy, Olenox targets long-term value in revitalizing overlooked oil and gas assets. Its operational model, combined with emerging infrastructure technology partnerships, aims to improve field performance while maintaining environmental compliance. Through this diversification, Safe and Green aligns its platform with infrastructure modernization, energy resilience, and sustainability imperatives.

Leadership Team

Michael McLaren, Chairman and Chief Executive Officer, brings over 30 years of leadership in the energy industry, including military and field service projects, mergers and acquisitions, and technology development. He is the founder of Olenox Ltd., a developer of proprietary energy systems, and holds advanced degrees in Science and Business from the University of British Columbia. McLaren has authored multiple papers on alternative fuels and energy systems and serves as a lead strategist for Safe and Green’s cross-sector growth.

Patricia Kaelin, CPA, Chief Financial Officer, has more than 30 years of experience in public company financial management, mergers and acquisitions, and strategic capital deployment. She previously served as CFO and CIO of a billion-dollar construction company overseeing operations across 14 states. Her background spans construction, healthcare, manufacturing, and real estate. Kaelin holds a bachelor’s degree in business administration with a concentration in accounting from California State University, Fullerton.

Jim Pendergast, Chief Operating Officer, has held executive leadership roles across multiple sectors, including energy, construction, and agriculture. He has served as COO, CFO, and CEO at public and private firms, overseeing operations, acquisitions, and project execution. He holds an MBA in international business and finance from McMaster University and a BA in political studies and economics from Queen’s University.

Safe and Green Holdings Corp. (NASDAQ: SGBX), closed Wednesday's trading session at $3.25, up 7.2607%, on 1,135,815 volume. The average volume for the last 3 months is 14,850,772 and the stock's 52-week low/high is $1.81/$122.88.

Recent News

• Safe and Green Holdings Corp. (NASDAQ: SGBX) - Safe & Green Holdings Corp. (NASDAQ: SGBX) Olenox Subsidiary Secures DOT Number as Service Division Prepares for Mobilization
• MissionIRNewsBreaks - Safe & Green Holdings Corp. (NASDAQ: SGBX) Mobilizes Service Assets Following Olenox DOT Approval
• Safe & Green Holdings Corp. (NASDAQ: SGBX) Sees Expanding Energy Demand a Key Factor in America's Push for Energy Independence

NRx Pharmaceuticals Inc. (NASDAQ: NRXP)

The QualityStocks Daily Newsletter would like to spotlight NRx Pharmaceuticals Inc. (NASDAQ: NRXP).

NRx Pharmaceuticals (NASDAQ: NRXP) , a clinical-stage biopharmaceutical company, said it amended its Investigational New Drug filing for NRX-101 to include use of the drug in combination with Transcranial Magnetic Stimulation for depression, including suicidal depression. The update follows evidence suggesting NRX-101 may significantly enhance TMS outcomes, with published studies showing more than two-fold improvements in symptom reduction and clinical response rates exceeding 80%. The Company noted NRX-101's D-cycloserine component appears to augment neuroplasticity associated with TMS, while its low-dose lurasidone is intended to mitigate D-cycloserine's known risk of low-grade hallucinations. NRx said it aims to validate the findings in a well-controlled trial of about 120 participants and is in partnership discussions with TMS device manufacturers to pursue joint registration studies and potential label augmentation.

To view the full press release, visit https://ibn.fm/LT0dZ

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) is a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system disorders, with a particular emphasis on conditions characterized by acute suicidality. The company is leveraging its proprietary NMDA receptor modulation platform to address significant unmet medical needs in suicidal depression, bipolar depression, chronic pain, and post-traumatic stress disorder (PTSD).

With a commitment to advancing life-saving treatments, NRx is developing novel therapeutics aimed at providing safer and more effective alternatives to current treatment options. Its lead investigational drug, NRX-101, is positioned to be the first FDA-approved oral therapy for suicidal bipolar depression. Additionally, the company is working to bring NRX-100 (intravenous ketamine) to market as an approved treatment for acute suicidal depression, a condition for which existing treatments remain limited.

By integrating cutting-edge science with a patient-focused mission, NRx aims to transform the standard of care for individuals suffering from severe psychiatric and neurological conditions.

NRx has also established HOPE Therapeutics, a subsidiary focused on delivering interventional psychiatric care through a nationwide clinic network. HOPE Therapeutics aims to become the first coordinated system of care for suicidal depression and PTSD, combining ketamine, Transcranial Magnetic Stimulation (TMS), digital therapeutics, and other precision psychiatry tools in a supervised clinical environment.

NRx is headquartered in Wilmington, Delaware. HOPE is headquartered in Miami, Florida.

Product Portfolio

NRx Pharmaceuticals’ pipeline includes multiple late-stage therapeutic candidates targeting psychiatric and neurological disorders:

• NRX-100: A preservative free intravenous ketamine formulation under development for acute suicidal depression, backed by strong clinical trial data and Fast Track designation from the FDA.
• NRX-101: An oral therapy with a dual mechanism targeting NMDA and 5-HT2A receptors, designed for patients with suicidal treatment-resistant bipolar depression. The drug has received Breakthrough Therapy designation from the FDA.
• Expanded Research: The company is further evaluating NRX-101 as a potential non-opioid treatment for chronic pain and a therapy for complicated urinary tract infections.

NRx’s therapeutic pipeline is designed to address conditions with limited or no treatment options, with the potential to improve patient outcomes and expand the standard of care.

HOPE Therapeutics

HOPE Therapeutics, a wholly owned subsidiary of NRx Pharmaceuticals, is establishing a national network of psychiatrist-led clinics focused on suicidal depression and PTSD. Its care model integrates preservative-free ketamine, TMS, digital therapeutics, and supervised psychiatric support to deliver rapid, measurable outcomes.

The company is targeting more than 30 clinic acquisitions by year-end 2025. Recent agreements include the acquisition of Dura Medical and a letter of intent with Neurospa TMS, strengthening HOPE’s foundation in interventional psychiatry. In April, HOPE also secured a term sheet for strategic investment from a global medical device manufacturer.

With ketamine sales already underway under a 503B license, HOPE projects $100 million in annual revenue and profitability by year-end 2025. Positioned as a standalone care delivery company, HOPE offers NRx a potential future spinout opportunity to unlock additional shareholder value.

Market Opportunity

The need for innovative treatments in mental health and pain management is substantial. Suicide is a leading cause of death in the United States, claiming nearly 50,000 lives each year, with over 12 million adults seriously considering suicide annually, according to the CDC.

Suicidal depression, a distinct and life-threatening condition, affects approximately 3.5 million Americans. Despite this prevalence, the only approved intervention remains electroconvulsive therapy (ECT), a treatment with significant side effects and limited access. NRx aims to address this urgent gap with NRX-100, a preservative-free intravenous ketamine formulation being developed as the first FDA-approved treatment specifically for suicidal depression.

Additionally, approximately 7 million Americans suffer from bipolar depression, a condition where nearly half of patients will attempt suicide during their lifetime and one in five may die by suicide. NRX-101, NRx’s oral drug candidate, targets this critical unmet need as a potential first-in-class therapy specifically for bipolar depression.

Beyond mood disorders, chronic pain affects over 50 million individuals in the U.S., and PTSD impacts more than 12 million people—conditions for which few non-opioid, fast-acting treatments are available. By addressing these high-risk, underserved populations, NRx Pharmaceuticals is positioned to enter multiple billion-dollar markets and reshape the standard of care for severe psychiatric and neurological illnesses.

Leadership Team

Jonathan C. Javitt, Founder, Chairman & Chief Executive Officer or NRx, and Co-CEO of HOPE, brings four decades of experience in pharmaceutical and medical device development. He has led blockbuster drug and device programs at major companies, including Allergan, Merck, and Novartis, and has served as an advisor to four U.S. presidential administrations.

Michael Abrams, Chief Financial Officer, has nearly 30 years of experience in finance, having served in executive roles, including CFO positions at Arch Therapeutics and FitLife Brands. His expertise spans investment banking, corporate finance, and business strategy.

Rick Panicucci, Chief Technology Officer, has more than 25 years of leadership in pharmaceutical manufacturing and process development. He has held key positions at Novartis, WuXi AppTec, and other major companies, leading multiple approved New Drug Applications.

Matthew Duffy, Chief Business Officer, NRx, Co-CEO of HOPE, has over 35 years of experience in biotechnology business development and investment banking. He has held leadership roles at Pfizer, MedImmune, and several financial institutions, specializing in corporate strategy and partnerships.

NRx Pharmaceuticals Inc. (NASDAQ: NRXP), closed Wednesday's trading session at $2.41, up 6.1674%, on 338,456 volume. The average volume for the last 3 months is 472,668 and the stock's 52-week low/high is $1.15/$6.01.

Recent News

• NRx Pharmaceuticals Inc. (NASDAQ: NRXP) - BioMedNewsBreaks - NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Amends IND to Advance NRX-101 With TMS for Depression Treatment
• InvestorNewsBreaks - NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Announces FDA Receipt of ANDA for KETAFREE With July 2026 Review Goal Date
• NetworkNewsBreaks - NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Schedules Corporate Update Call for Dec. 2

Micropolis Holding Co. (NYSE American: MCRP)

The QualityStocks Daily Newsletter would like to spotlight Micropolis Holding Co. (NYSE American: MCRP).

Micropolis AI Robotics (NYSE American: MCRP) , a UAE-based developer of autonomous mobile robots and AI-driven security solutions, said it signed a non-binding Letter of Intent with QSS Robotics to establish a strategic collaboration for the distribution, localization, and deployment of Micropolis technologies across Saudi Arabia. The LOI outlines plans for commercial representation, joint engagement with government and private-sector customers, and integration and after-sales support under Micropolis supervision, building on agreements between the companies dating to 2022. Micropolis will provide its full suite of technologies, including M01 and M02 autonomous mobility platforms, Mission Planner and HD Mapping systems, Tele-Operator tools, and Microspot AI modules. QSS Robotics will act as Micropolis' commercial and technical partner in the Kingdom. CEO Fareed Aljawhari said the agreement expands the Company's reach in Saudi Arabia and reflects the strong alignment between the two companies.

To view the full press release, visit https://ibn.fm/EHEat

Micropolis Holding Co. (NYSE American: MCRP) is a robotics and AI technology company pioneering the development of unmanned ground vehicles (UGVs), autonomous mobility platforms, and smart infrastructure for security, industrial, and urban applications. Since its founding in 2014, the company has evolved from a software startup into a fully integrated robotics manufacturer with expertise spanning mechatronics, embedded systems, AI software, and high-level autonomy. Its core technology is centered on modularity and adaptability, enabling Micropolis to deploy scalable robotics solutions across a wide range of industries and environments.

The company’s mission is rooted in a vision of harmonious human-machine collaboration, where intelligent automation drives sustainable progress. Through a growing portfolio of partnerships with public and private sector clients, including defense agencies, municipalities, and industrial operators, Micropolis aims to transform how the world approaches mobility, surveillance, and operational efficiency. These solutions are engineered not just to automate tasks, but to meaningfully enhance safety, sustainability, and strategic readiness in high-impact environments.

Following its initial public offering on the NYSE American in March 2025, Micropolis has accelerated the rollout of its autonomous platforms through regional pilots, strategic agreements, and ongoing R&D efforts.

The company is headquartered in Dubai, UAE.

Products

Micropolis offers a robust portfolio of autonomous robotics platforms, control systems, and AI software designed to meet the complex needs of security, industrial, and smart city applications.

M-Platform

Micropolis’ core robotics architecture is built around the M-Platform, a modular autonomous system composed of two primary components: a Mobility-Specific Platform (MSP) and an Application-Specific Pod (ASP). The MSP includes drive-by-wire and steer-by-wire systems, a custom suspension framework, and integrated power storage, all designed for durability and maneuverability in both urban and off-road environments. These platforms are compatible with a wide range of ASPs, enabling the same robotic base to be rapidly reconfigured for use cases in law enforcement, logistics, environmental cleanup, or public safety.

Advanced features across the platform include autonomous driving software, centralized control units, and AI-enhanced power management. Supporting technologies such as the Micropolis Robotic Control Unit (MRCU) and Smart Power Distribution Unit (SPDU) ensure high reliability, energy efficiency, and seamless integration with third-party systems. A compact mechanical design, high-precision control, and in-house R&D allow for scalable customization to match industry-specific requirements.

M-Patrol

The M-Patrol series includes specialized autonomous security and policing robots developed in collaboration with Dubai Police and other governmental entities. The M01 Patrol Unit is designed for open-road deployment, with speeds of 40–47 km/h and features like 360-degree AI vision, license plate recognition, crowd monitoring, and autonomous navigation. It is suited for high-traffic environments where rapid mobility and broad coverage are required.

The M02 Patrol Unit is built for enclosed or pedestrian-rich settings such as gated communities, offering a top speed of 7–10 km/h. It delivers low-speed, high-precision surveillance while maintaining safety in public-facing operations. In August 2025, Micropolis launched the final testing phase of the M02 platform in partnership with Dubai Expo City, Transguard Group, and Dubai Police. This pilot focused on validating advanced features including facial recognition, suspect tracking, behavior analysis, and autonomous navigation. Like the M01, the M02 is compatible with Micropolis’ proprietary command systems and can operate autonomously or under remote supervision.

Microspot

Microspot is Micropolis’ proprietary AI surveillance and analytics engine integrated into its robotic platforms. Initially co-developed with Dubai Police, Microspot enables real-time behavior analysis, facial recognition, and license plate detection through edge computing and machine learning algorithms. It is optimized for public safety use cases where rapid threat identification and decentralized processing are critical.

Micropolis’ recent agreement with AERXIO grants exclusive distribution rights of the company’s “Patrol” system, powered by Microspot, across Egypt and North Africa. This variant is engineered for border and desert operations, featuring a top speed of 50 km/h, a 15-hour runtime, and rapid charging capabilities. The integration of Microspot technology into these units allows for scalable deployment in both civilian and defense-oriented surveillance infrastructure.

Market Opportunity

Micropolis is strategically positioned to serve the growing demand for autonomous robotics and AI-powered systems across the Gulf Cooperation Council (GCC) and beyond. The company’s solutions address operational needs in urban security, logistics, defense, infrastructure, and environmental management—sectors that are undergoing rapid digital transformation in the Middle East.

Government initiatives in the UAE and Saudi Arabia have propelled the robotics and AI markets forward through funding, regulation, and institutional support. The UAE’s Strategy for Artificial Intelligence and Saudi Arabia’s Vision 2030 have created long-term national frameworks for automation and smart infrastructure adoption. Micropolis’ collaboration with public-sector partners, such as Dubai Police and SEE Holding’s Sustainable City 2.0, is aligned with these policy objectives and reflects growing national demand for autonomous technology.

Leadership Team

Fareed Aljawhari, Founder, Chief Executive Officer & Director, is a seasoned product designer and digital developer with over two decades of experience in Dubai’s digital transformation landscape. He founded Micropolis in 2014 and has led its evolution into a robotics and AI enterprise. He has cultivated strong relationships with government and private entities across the UAE, helping to position the company at the forefront of the region’s technology ecosystem.

Dzmitry Kastahorau, Chief Financial Officer, is a finance executive with international experience across the luxury retail, fashion, and automotive sectors. He holds a master’s degree in international corporate finance from EADA Business School in Barcelona and has previously held senior finance roles at Chalhoub Group, PUIG Spain, and Motherson Automotive in Germany.

Micropolis Holding Co. (NYSE American: MCRP), closed Wednesday's trading session at $1.18, up 51.2821%, on 10,882,017 volume. The average volume for the last 3 months is 633,993 and the stock's 52-week low/high is $0.6882/$5.64.

Recent News

• Micropolis Holding Co. (NYSE American: MCRP) - TechMediaBreaks - Micropolis AI Robotics (NYSE: MCRP) Signs LOI With QSS Robotics to Expand Deployment in Saudi Arabia
• TechMediaBreaks - Micropolis Holding Co. (NYSE American: MCRP) Launches Industrial-Grade Edge Computing Unit Powered by NVIDIA Orin
• NetworkNewsBreaks - Micropolis Holding Co. (NYSE American: MCRP) Featured on New Episode of IBN's TechMediaWire Podcast

Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF)

The QualityStocks Daily Newsletter would like to spotlight Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF).

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising.

The company completed its first milestone payment and share issuance under the option agreement to acquire 100% of the Pinard Rare Earths Project in northern Ontario.

The Pinard project covers 255 contiguous claims across 5,178 hectares within an alkaline intrusive complex comparable to nearby REE-bearing systems.

A new geoscience interpretation at Atikokan Project identified multiple high-priority REE targets, including a structural–geochemical corridor with TREE values up to 1,947 ppm.

Powermax continues to build a diversified REE portfolio across Ontario, British Columbia, and Wyoming, including its 100%-owned Ogden Bear Lodge Project bordering a U.S. DOE–funded REE district.

Global demand for rare earth elements is projected to triple by 2035, underscoring the strategic significance of North American REE exploration amid policies supporting domestic supply chains.

Powermax Minerals (CSE: PMAX) (OTCQB: PWMXF) , a Canadian mineral exploration company, continued expanding its rare earth element ("REE") exploration portfolio in November, completing its initial milestone payment and share issuance toward the acquisition of the Pinard Rare Earths Project in northern Ontario. The company confirmed the transaction in a November 13 update, marking progress on a multi-year option agreement that could ultimately give Powermax full ownership of the 5,178-hectare property ( https://ibn.fm/0kvU7 ).

Disseminated on behalf of Powermax Minerals Inc., may include paid advertisements.

Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) is a Canadian mineral exploration company developing a portfolio of rare earth element (“REE”) projects across Tier-1 jurisdictions in Canada and the United States. Focused on discovery, responsible advancement, and alignment with North America’s critical-minerals strategy, the company targets areas with geological potential for REE-bearing pegmatites and granitic systems.

Its exploration model emphasizes modern geophysics, data integration, and systematic de-risking through technical work. By concentrating on projects with clear infrastructure advantages and policy support, Powermax seeks to contribute meaningfully to regional supply-chain independence in critical minerals vital to electrification and advanced manufacturing.

The company’s growing asset base includes four core REE projects, Atikokan, Cameron, Pinard and Ogden Bear Lodge, positioned within highly prospective geological corridors.

Powermax Minerals is headquartered in Toronto, Ontario.

Projects

Atikokan REE Project – Northwestern Ontario

Powermax’s flagship Atikokan Rare Earth Element Project covers 9,416 hectares across three mineral claim blocks (A, B, and C) approximately 35 kilometers northwest of the town of Atikokan in the Thunder Bay Mining District. Located along the White Otter–Dashwa corridor, the project hosts REE-enriched granitic and pegmatitic systems supported by strong radiometric and geochemical signatures.

In 2025, Powermax completed airborne magnetic and gamma-ray spectrometric surveys, geological mapping, and geochemical sampling. An integrated interpretation released in November 2025 outlined a structural–geochemical corridor of REE enrichment, with Total Rare Earth Element (TREE) values from 254 ppm to 1,947 ppm across Blocks B and C. The company is currently advancing surface validation and target ranking for follow-up work.

Cameron REE Project – British Columbia

The Cameron Project, which the company holds an option to acquire, is located about 30 kilometers south of Revelstoke in the Kamloops Mining Division and comprises three contiguous mineral claims totaling 2,984 hectares.

Hosted within the Monashee Group, the property contains NYF-type granitic pegmatites and gneissic units known to carry both light and heavy REEs. Phase 1 exploration, completed under NI 43-101 recommendations, produced TREE values ranging from 17 ppm to 1,943 ppm, with heavy mineral concentrate samples up to 7,561 ppm. These findings confirmed consistent REE enrichment and led to the launch of Phase 2 exploration in October 2025 to expand mapping and refine drill targets.

Ogden Bear Lodge REE Project – Wyoming, USA

Powermax owns a 100% interest in the Ogden Bear Lodge Project, covering 22 lode claims (184 hectares) in Crook County, Wyoming. The property is prospective for high-grade neodymium-praseodymium (Nd/Pr) oxide mineralization and shares a border with Rare Element Resources’ Bear Lodge Critical Rare Earth Project. That neighboring project has received $24.2 million in U.S. Department of Energy support and a non-binding EXIM Bank letter of interest for up to $553 million in debt financing, highlighting the strategic value of this emerging U.S. REE district.

Pinard Rare Earths Project – Northern Ontario

In November 2025, Powermax Minerals announced plans to acquire a 100% interest in the Pinard Rare Earths Project, located roughly 70 kilometers north-northeast of Kapuskasing, Ontario. The property consists of 255 contiguous claims totaling 5,178 hectares within the Pinard Intrusive Rock Complex, an alkaline igneous system characterized by nepheline syenites and peralkaline granites commonly associated with REE-bearing mineralization.

Market Opportunity

Global demand for rare earth elements is projected to triple—from 59,000 tonnes in 2022 to 176,000 tonnes by 2035—driven by rapid electric-vehicle adoption and wind-power expansion, with supply expected to lag by up to 30%. The global REE market, valued at $3.95 billion in 2024, is forecast to reach $6.3 billion by 2030 at a compound annual growth rate of approximately 8.6%, according to Grand View Research.

China currently controls approximately 60% of REE mining and about 90% of processing capacity, prompting North American governments to accelerate domestic development. In 2025, the U.S. Department of Energy announced $1 billion in critical-minerals funding opportunities, while Canada’s C$1.5 billion Critical Minerals Infrastructure Fund supports projects through 2030. Together, this policy support and structural supply deficit highlight Powermax’s positioning within a strategically essential market tied to the clean-energy transition.

Leadership Team

Paul Gorman, CEO & Director, is a resource-based corporate specialist with more than 25 years of experience in junior mining finance, public listings, and corporate development. He is the President and Managing Partner of Riverbank Capital Inc., where he has raised over $150 million for emerging issuers and helped revitalize the North American graphite industry through the founding of Mega Graphite Inc. Gorman has led multiple exploration programs and was instrumental in achieving high-grade lithium discoveries in 2024 for Pan American Energy Corp.

Michael Malana, Director, has more than 20 years of international experience in financial management, reporting, and corporate governance. He has held senior executive roles across natural resources, biotechnology, and manufacturing and holds a Bachelor of Commerce degree from Concordia University in Montreal. Malana is a Chartered Professional Accountant (Certified Management Accountant).

Afzaal Pirzada, M.Sc., P.Geo., Director, is a professional geoscientist with over 30 years of experience in mineral exploration and mining, specializing in gold, lithium, graphite, rare metals, and uranium. He has served as Project Geologist, VP Exploration, Director, and CEO for multiple mining companies, including Adriana Resources and Rock Tech Lithium. Pirzada is a registered Professional Geoscientist with Engineers and Geoscientists British Columbia and has authored numerous NI 43-101 technical reports.

Powermax Minerals Inc. (OTCQB: PWMXF), closed Wednesday's trading session at $1.016, up 2.6263%, on 81,182 volume. The average volume for the last 3 months is 160,500 and the stock's 52-week low/high is $0.6116/$1.45.

Recent News

• Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) - NetworkNewsBreaks - Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) (FSE: T23) Completes Phase 2 Field Program at Cameron REE Project in British Columbia
• MiningNewsBreaks - Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) (FSE: T23) Completes High-Resolution Airborne Survey Over Atikokan REE Property
• RockBreaks - Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) (FSE: T23) Expands Global Investor Access With New International Listings

Soligenix Inc. (NASDAQ: SNGX)

The QualityStocks Daily Newsletter would like to spotlight Soligenix Inc. (NASDAQ: SNGX).

Soligenix (NASDAQ: SNGX) was featured in a BioMedWire editorial titled "Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now," which examines the growing burden of rare diseases affecting more than 30 million Americans and the urgent need for new therapies. The article spotlights Soligenix's late-stage development of HyBryte(TM) (synthetic hypericin) for cutaneous T-cell lymphoma, now in its final confirmatory study before worldwide marketing submissions, and places the Company's efforts at the intersection of advancing treatment options and emerging national health policy initiatives.

To view the full press release, visit https://ibn.fm/OFZZt

Soligenix Inc. (NASDAQ: SNGX) is a late-stage biopharmaceutical company focused on developing and commercializing treatments for rare diseases with high unmet medical needs. Operating through two key segments, the company’s Specialized BioTherapeutics division is dedicated to oncology and inflammation therapies, while its Public Health Solutions segment advances vaccines and therapeutics targeting biothreats and infectious diseases.

The company is actively advancing multiple late-stage clinical programs, including HyBryte™ (SGX301), a novel photodynamic therapy for cutaneous T-cell lymphoma (CTCL). Additional candidates in development target psoriasis (SGX302), oral mucositis (SGX942), and Behçet’s disease (SGX945), while its public health efforts focus on heat-stable vaccines for ricin poisoning (RiVax®), Ebola (SuVax™), and Marburg (MarVax™) viruses, that have been supported by non-dilutive government grants and contracts of approximately $60 million to date.

With a diversified pipeline, multiple orphan and fast-track designations, and collaborations with government agencies, Soligenix is uniquely positioned for potential regulatory approvals and commercialization.

The company is headquartered in Princeton, New Jersey.

Pipeline and Development Programs

Specialized BioTherapeutics

Soligenix’s Specialized BioTherapeutics division develops treatments for oncology and inflammatory diseases, focusing on conditions with few or no effective therapeutic options. HyBryte™ (synthetic hypericin) has completed a Phase 3 study for CTCL, demonstrating statistically significant efficacy, and a second confirmatory Phase 3 trial is actively enrolling patients to support potential regulatory submissions worldwide. If approved, it would be the first non-mutagenic photodynamic therapy for early-stage CTCL, addressing an unmet medical need. It has received orphan drug designations in the U.S. and Europe, as well as Fast Track designation in the U.S.

SGX302, a photodynamic therapy based on the same active ingredient as HyBryte™, is in clinical development for mild-to-moderate psoriasis, with positive Phase 1/2 proof-of-concept results, it is actively enrolling patients in a Phase 2a clinical trial.

SGX942, designed to reduce inflammation and tissue damage in oral mucositis associated with cancer treatment, is progressing as a potential first-in-class therapy.
SGX945, targeting aphthous ulcers in Behçet’s disease, is actively enrolling in a Phase 2a clinical trial and has received fast-track designation, highlighting the urgency of developing effective treatments for this rare inflammatory condition.

Public Health Solutions

The company’s Public Health Solutions segment focuses on medical countermeasures for biothreats and emerging infectious diseases, leveraging non-dilutive government funding to advance its programs. RiVax®, a ricin toxin vaccine, has demonstrated strong preclinical and early clinical results and may be eligible for government procurement under the Strategic National Stockpile initiative.

The company’s RiVax®, as well as its vaccine candidates for Ebola and Marburg viruses are based on its proprietary ThermoVax® technology, which stabilizes vaccines for long-term storage without refrigeration. This approach could be transformative in regions where maintaining cold-chain logistics is challenging.

The ongoing development of these vaccines is supported by funding from NIH, BARDA, and DTRA, with the potential for up to three priority review vouchers (PRVs) upon regulatory approval, to be used for future programs or sold. Notably, PRVs have previously sold for roughly $100 million.

Market Opportunity

Soligenix targets markets with significant commercial potential, focusing on rare diseases and biodefense applications. HyBryte™ addresses CTCL, a disease affecting over 68,000 patients across the U.S. and Europe, with a total market opportunity exceeding $250 million. SGX302, the company’s therapy for mild-to-moderate psoriasis, serves a much larger population, as over eight million people in the U.S. are affected by the condition, representing a global market opportunity exceeding $1 billion.

SGX942, developed for oral mucositis in head and neck cancer patients, is aimed at a market worth more than $500 million, while SGX945 for Behçet’s disease serves a niche segment valued at over $200 million worldwide.

In addition to its rare disease programs, Soligenix’s Public Health Solutions division has the potential to generate significant revenue through government procurement contracts. By focusing on both orphan drug markets and government-funded biodefense initiatives, Soligenix has positioned itself for sustained revenue growth through multiple high-value opportunities.

Leadership Team

Christopher J. Schaber, PhD, Chairman, President & CEO, brings to the company more than 35 years of experience in the biopharmaceutical industry. Before joining Soligenix, he held senior and operational leadership roles at Discovery Laboratories, Acute Therapeutics, Ohmeda Pharmaceuticals, The Liposome Company, and Wyeth Ayerst Laboratories. He has extensive expertise in drug development, regulatory affairs, and corporate strategy, positioning him to drive Soligenix’s growth and advancement toward commercialization.

Richard Straube, MD, Chief Medical Officer, has more than 35 years of experience in drug development and clinical research. Prior to joining Soligenix, he held key leadership roles at Stealth Peptides, INO Therapeutics, Ohmeda Pharmaceuticals, and Centocor. Throughout his career, he has played a crucial role in bringing innovative therapies to market, particularly in inflammatory diseases and immunology, making him a valuable asset in advancing Soligenix’s late-stage clinical programs.

Oreola Donini, PhD, Chief Scientific Officer, has more than 20 years of experience in pharmaceutical research and development, with expertise in immunology, inflammation, and rare diseases. Before joining Soligenix, she held leadership positions at Inimex Pharmaceuticals, ESSA Pharma, and Kinetek Pharmaceuticals, where she worked on novel drug discovery and translational medicine. Her experience in preclinical research and product development supports Soligenix’s continued innovation in biopharmaceuticals.

Jonathan Guarino, CPA, CGMA, Chief Financial Officer, has over 25 years of experience in corporate finance and strategic financial planning. Before joining Soligenix, he held financial leadership positions at Hepion Pharmaceuticals, Covance, BlackRock, and Barnes & Noble. His expertise in financial management, accounting, and capital markets plays a critical role in Soligenix’s financial strategy and operational efficiency.

Soligenix Inc. (NASDAQ: SNGX), closed Wednesday's trading session at $1.55, off by 1.8987%, on 202,368 volume. The average volume for the last 3 months is 266,859 and the stock's 52-week low/high is $1.09/$6.2299.

Recent News

• Soligenix Inc. (NASDAQ: SNGX) - InvestorNewsBreaks - Soligenix Inc. (NASDAQ: SNGX) Featured in BioMedWire Editorial Highlighting HyBryte(TM) and Rare Disease Policy
• Study Uncovers Surprising Connection Between Choline, Obesity and Brain Inflammation
• Soligenix Inc. (NASDAQ: SNGX) Reaches Key Enrollment Milestone in Phase 3 Trial with Encouraging Blinded Response Rate

Oncotelic Therapeutics Inc. (OTCQB: OTLC)

The QualityStocks Daily Newsletter would like to spotlight Oncotelic Therapeutics Inc. (OTCQB: OTLC).

Oncotelic Therapeutics (OTCQB: OTLC) , 45% owner of the Sapu Nano joint venture, announced new pharmacokinetic and tissue-distribution data showing that Sapu003, its intravenous Deciparticle (TM) formulation of everolimus, dramatically reduces gastrointestinal drug accumulation compared with oral everolimus. Oral dosing drives extreme gut exposure—up to 2,448× plasma levels in the stomach—while IV Sapu003 limits GI tissue levels to just 36–48× plasma, representing reductions of up to 67-fold. The company stated that this shift may improve tolerability, maintain the drug's intrinsic metabolic profile, and provide more consistent systemic exposure.

To view the full press release, visit https://ibn.fm/dVPuX

Oncotelic Therapeutics Inc. (OTCQB: OTLC) is a clinical-stage biopharmaceutical company developing RNA-based, immunotherapy, and targeted therapeutics for cancer and other underserved diseases. The company is focused on transforming outcomes for patients with difficult-to-treat and rare conditions, particularly pediatric cancers and aggressive solid tumors. Its development strategy centers on novel compound design, nanoparticle drug delivery, and the integration of artificial intelligence to accelerate discovery and regulatory workflows.

At the center of this foundation is Chairman and CEO Dr. Vuong Trieu, a prolific industry pioneer who has filed more than 500 patents with 75 issued patents across biologics, small molecules, nanoparticles, and diagnostics. Dr. Trieu co-invented Abraxane® (sold to Celgene for $2.9 billion), underscoring his track record of creating high-value therapies. Through collaborations with industry leaders and its stake in specialized joint ventures, Oncotelic is positioned to advance a diverse portfolio of oncology assets with greater speed and cost efficiency. The company also operates a proprietary AI platform, PDAOAI, which streamlines scientific writing, regulatory documentation, and data interpretation. This system is accessible to the public through a dedicated Discord server, offering real-time engagement with Oncotelic’s research ecosystem.

With expanded clinical activity and a next-generation development model, Oncotelic continues to evolve as a multi-asset innovator in precision oncology.

The company is headquartered in Agoura Hills, California.

Pipeline and Partnerships

Oncotelic’s lead candidate is OT-101, currently in a Phase 3 trial for pancreatic ductal adenocarcinoma (STOP-PC study) and evaluated in gliomas and metastatic solid tumors in combination with IL-2 and checkpoint inhibitors. The antisense molecule targets TGF-β2, a cytokine known to suppress immune responses and promote tumor growth. A Phase 1 trial combining OT-101 with IL-2 was recently completed, demonstrating safety and paving the way for combination therapies with PD-1 blockers and other immunotherapies.

Recent data have further strengthened the rationale for OT-101 in pancreatic ductal adenocarcinoma (PDAC). In June and July 2025, two peer-reviewed studies published in the International Journal of Molecular Sciences identified TGF-β2 gene expression and methylation status as significant prognostic markers in PDAC, particularly among younger patients and those with low CD8+ T-cell infiltration. High TGF-β2 expression correlated with reduced overall survival, while elevated TGF-β2 methylation was associated with improved outcomes. These findings validate TGF-β2 as a high-priority target and support the continued development of OT-101 as a precision therapy. Both studies leveraged Oncotelic’s proprietary AI-driven platform, PDAOAI, to mine and assemble multi-omic datasets, showcasing the system’s role in accelerating insight generation.

The company holds a 45% ownership stake in GMP Biotechnology Limited, a joint venture with Dragon Capital Overseas Limited. GMP Bio owns SAPU Bioscience, which is executing several pipeline programs. SAPU and Oncotelic are jointly utilizing a rapid IND platform through their partnership with Shanghai Medicilon to support regulatory filings for up to 20 drug candidates, with five INDs already underway. This collaboration is central to accelerating development of next-generation anticancer agents.

After the joint venture, Dr. Trieu, with his team, built out a state of the art and GMP-certified R&D facility in San Diego, which operates under SAPU, that manufactures clinical trial materials and supports a proprietary nanoparticle platform trademarked Deciparticle ™. This platform includes four therapeutic candidates—two of which are in late-stage manufacturing and expected to enter IND filing before the end of 2025.

Additionally, Oncotelic owns AL-101, an intranasal administered apomorphine product intended for the treatment of Parkinson’s disease, Erectile Dysfunction, and Female Sexual Disorders.

Market Opportunity

Oncotelic is targeting large and underserved therapeutic markets with significant commercial potentials. The global pancreatic cancer treatment market alone is projected to grow at a 12.3% CAGR, reaching $5.84 billion by 2030, up from $2.92 billion in 2024, according to Research and Markets. This growth is driven by increased disease prevalence, aging populations, and demand for more effective treatment options. Notably, the incidence of early-onset PDAC is rising at an estimated rate of 4% per year in the 15–34 age group, highlighting an emerging unmet need for targeted therapies among younger patients.

Beyond oncology, Oncotelic intends to develop AL-101 for Parkinson’s disease, which affects over 1 million patients in the U.S. alone and is expected to impact 1.2 million by 2030. Erectile Dysfunction and Female Sexual Dysfunction are also major global health issues, with Erectile Dysfunction affecting up to 70% of men over 60 and Female Sexual Dysfunction impacting approximately 40% of women—both with limited treatment options, particularly for patients who fail to respond to existing medications. These underserved populations offer fertile ground for innovative new therapies.

Leadership Team

Dr. Vuong Trieu is the Chairman and CEO of Oncotelic Inc. An accomplished innovator in pharmaceutical development, Dr. Trieu previously served as President and CEO of Igdrasol, where he pioneered the approval path for paclitaxel nanomedicine via a single bioequivalence trial. After Igdrasol merged with Sorrento Therapeutics, he became Chief Scientific Officer and a Board Director. He also held leadership roles at Cenomed, Abraxis, Applied Molecular Evolution, and Parker Hughes Institute. Dr. Trieu holds a Ph.D. in Molecular Microbiology, a B.S. in Botany, has published widely, and filed over 500 patent applications with 75 issued U.S. patents.

Amit Shah is the Chief Financial Officer of Oncotelic Inc. He has over 20 years of financial leadership in life sciences, including CFO roles at Marina Biotech and Igdrasol, and senior positions at ISTA Pharmaceuticals, Spectrum Pharmaceuticals, and Caraco. He also worked in consulting and ERP implementation. Mr. Shah holds a Bachelor of Commerce from the University of Mumbai, is an Associate Chartered Accountant in India, and is an inactive CPA in Colorado.

Dr. Anthony E. Maida III is the Chief Clinical Officer – Translational Medicine at Oncotelic Inc. He has over 25 years of experience advancing cancer immunotherapies and held senior roles at Northwest Biotherapeutics, PharmaNet, and Jenner Biotherapies. He has raised over $200 million for biotech firms and negotiated licensing deals with institutions such as Pfizer, Eli Lilly, and Yale. Dr. Maida holds dual B.A. degrees in Biology and History, an MBA, an M.A. in Toxicology, and a Ph.D. in Immunology, and is active in ASCO, AACR, and other scientific societies.

Oncotelic Therapeutics Inc. (OTCQB: OTLC), closed Wednesday's trading session at $0.091875, off by 0.0272035%, on 247,529 volume. The average volume for the last 3 months is 260,580 and the stock's 52-week low/high is $0.02403/$0.11.

Recent News

• Oncotelic Therapeutics Inc. (OTCQB: OTLC) - BioMedNewsBreaks - Oncotelic Therapeutics, Inc. (OTCQB: OTLC) 45% JV Reports IV Sapu003 Cuts GI Exposure to Everolimus by Up to 67-Fold
• NetworkNewsBreaks - Oncotelic Therapeutics, Inc. (OTCQB: OTLC) JV Sapu Nano Presents Data Showing Deciparticle Platform Supports Broad Hydrophobic Drug Formulation
• BioMedNewsBreaks - Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial on Biotech Valuation Trends

Search Minerals Inc. (TSX.V: SMY) (OTC: SHCMF)

Disseminated on behalf of Search Minerals Inc., may include paid advertisements.

The QualityStocks Daily Newsletter would like to spotlight Search Minerals Inc. (TSX.V: SMY) (OTC: SHCMF).

Search Minerals Inc. (TSX.V: SMY) (OTC: SHCMF) is a mineral exploration and development company focused on advancing critical rare earth element (“CREE”) resources in Labrador, Canada. Since its establishment, the company has concentrated on systematic exploration supported by detailed geological work, extensive sampling, and disciplined technical evaluation across its landholdings.

The company operates with an emphasis on transparency, field-based science, and engagement with local communities and partners, including the NunatuKavut Community Council and municipal leaders in the surrounding region. Its technical programs and community initiatives reflect an ongoing commitment to responsible exploration and long-term regional collaboration.

Through continued exploration, environmental review, and stakeholder dialogue, Search Minerals is working to advance its rare earth assets toward future development within a supportive and mining-friendly jurisdiction.

The company is headquartered in St. Lewis, Newfoundland and Labrador.

Projects

Port Hope Simpson – St. Lewis CREE District

Deep Fox

Deep Fox has emerged as Search Minerals’ leading resource, supported by extensive drilling, channel sampling, and feasibility-related technical work. Located 2 km northeast of St. Lewis with direct road and tidewater access, the project has been defined through 137 drill holes (25,741 m), 44 channels (1,096 m), geophysical surveys, and nearly 15,500 assays. Mineralization is hosted in steeply dipping pantellerite and extends up to 42 m thick across an approximate 400 m strike length. Phase 4 programs confirmed strong Nd–Pr–Dy–Tb values from surface to at least 200 m depth and expanded the zone both east and west. These results will support an updated mineral resource estimate and advance Deep Fox toward feasibility-level assessment.

Foxtrot

Foxtrot, the company’s first major discovery, lies 10 km west of St. Lewis and has been advanced through extensive work programs including 1,484 channel samples, 72 drill holes, mapping, and geophysics. The mineralized zone is well understood from surface to depth, with consistent alignment between channel and drill core assays. Foxtrot hosts an indicated resource of 10.04 million tonnes and an inferred resource of 3.00 million tonnes (December 2021), and forms part of the combined 2022 mineral resource estimate alongside Deep Fox.

Fox Meadow

Fox Meadow is a large-scale, high-priority exploration target located 11 km west of Port Hope Simpson. The mineralized zone is up to 175 m wide with a current strike length of 680 m, supported by magnetic anomalies extending over 1 km. Channel results indicate more moderate grades than Deep Fox and Foxtrot, but the scale and notably low uranium and thorium values present compelling advantages. Mineralization is structurally complex and hosted in trachytic pantellerites enriched in allanite, fergusonite, and zircon. A 2,000 m drill campaign and additional channel sampling were completed in late 2022, with results pending.

Other Prospects Along the Belt

Search Minerals controls multiple additional discoveries across its 64 km Fox Harbour volcanic belt:

• Silver Fox hosts high-grade zirconium, hafnium, and rare earths, with channel samples showing Zr concentrations surpassing 25,000 ppm.
• Awesome Fox contains strong Nd–Pr–Dy–Tb values across several wide channel intervals.
• Foxy Lady, Fox Run, and Krazy Fox exhibit CREE-enriched mineralization within the same peralkaline stratigraphy that hosts Deep Fox and Foxtrot.

These prospects collectively reinforce the district’s potential to support multiple future development opportunities beyond the flagship assets.

Red Wine CREE District

Search Minerals also controls 17 licenses (427 claims) in central Labrador within the Red Wine CREE District, prospective for both light and heavy rare earth elements as well as niobium and beryllium. Key prospects include Two Tom Lake, Mann #1, Merlot, Dory Pond, Cabernet, and Barbera. Channel assays released in 2025 confirmed significant concentrations of Nb, Be, Nd, Pr, Dy, and Tb across multiple targets. This district remains at an earlier stage but represents long-term upside, with ongoing prospecting, mapping, and additional channel sampling planned to prepare for future drilling.

Market Opportunity

Global demand for rare earth elements is projected to triple from 59,000 tonnes in 2022 to 176,000 tonnes by 2035 as electric-vehicle adoption accelerates and wind-power capacity expands. The global REE market, valued at $3.95 billion in 2024, is expected to reach $6.3 billion by 2030 at a compound annual growth rate of approximately 8.6%, according to Grand View Research. With supply projected to lag demand by as much as 30%, the outlook points to a sustained structural deficit in key magnet materials.

China currently controls roughly 60% of global REE mining and about 90% of processing capacity, prompting major efforts in North America to strengthen domestic supply chains. In 2025, the U.S. Department of Energy announced $1 billion in critical-minerals funding programs, while Canada’s C$1.5 billion Critical Minerals Infrastructure Fund will support project development through 2030. These initiatives underscore the importance of strengthening domestic rare earth supply chains.

In this environment of rising demand, constrained supply, and coordinated policy support, Search Minerals’ district-scale assets position the company within one of the most strategically vital segments of the clean-energy transition.

Leadership Team

Joseph Lanzon, Chief Executive Officer and Director, brings extensive experience in government relations, strategic communications, and high-level advocacy across regulatory, legislative, and capital markets environments. His background includes promoting shareholder interests at the Toronto Stock Exchange and navigating complex policy landscapes, with a strong foundation in strategic messaging, negotiation, and relationship building.

Jason Macintosh, Chief Financial Officer, brings more than 25 years of comprehensive finance leadership experience. He previously served as CFO and Corporate Secretary for STLLR Gold Inc., where he oversaw accounting and finance operations, established financial controls, and aligned financial strategy with the company’s broader growth and exploration objectives.

Dr. Randy Miller, Vice President, Exploration, holds a Ph.D. in Geology from the University of Toronto and is a registered Professional Geoscientist in Newfoundland and Labrador. He brings extensive rare earth element experience, including work on the Strange Lake deposit and 12 years as the province’s Rare Earth Element and Rare Metal Specialist. His research across Labrador and Newfoundland underpins Search’s exploration model, and he has been with the company since 2009.

Ed Moriarity, Vice President, Environment and External Relations, brings over 25 years of experience across private industry, government, and the non-profit sector. He previously served as Executive Director of Mining Industry NL and as a Director of Communications with the Government of Newfoundland and Labrador, and now leads Search’s environmental engagement and partnership work with the NunatuKavut Community Council. He holds a BA from Memorial University and a Postgraduate Diploma in Business Administration from the University of Roehampton-London.

Search Minerals Inc. (OTC: SHCMF), closed Wednesday's trading session at $0.36329, up 3.9694%, on 1,600 volume. The average volume for the last 3 months is 5,870 and the stock's 52-week low/high is $0.069/$0.6083.

Recent News

• Search Minerals Inc. (TSX.V: SMY) (OTC: SHCMF) - Search Minerals Inc. (TSX.V: SMY) (OTC: SHCMF) Is 'One to Watch'
• Search Minerals Inc. (TSX.V: SMY) (OTC: SHCMF) Strengthens Canadian Critical Rare Earth Exploration with Award-Winning Geoscience Leadership
• Search Minerals Inc. (TSX.V: SMY) (OTC: SHCMF) Strengthens Canadian Critical Rare Earth Exploration with Award-Winning Geoscience Leadership

SEGG Media Corp. (NASDAQ: SEGG)

The QualityStocks Daily Newsletter would like to spotlight SEGG Media Corp. (NASDAQ: SEGG).

SEGG Media Corp. (NASDAQ: SEGG; LTRYW) is a global sports, entertainment, and gaming company redefining how audiences connect with content through immersive technology and ethical engagement. Formerly known as Lottery.com Inc., the company recently completed a comprehensive corporate transformation, rebranding as SEGG Media (short for Sports Entertainment Gaming Global Media) to reflect its new strategic direction and structural overhaul.

With a mission to fuse real-time experiences, fan-first platforms, and responsible innovation, SEGG Media operates at the intersection of sports, entertainment, and gaming. Its business model is built around three synergistic verticals, each designed to scale globally while delivering meaningful value to fans, partners, and shareholders.

From sim racing and esports to live event streaming and charitable gaming, SEGG Media is building a next-generation platform that redefines how audiences interact with their favorite content and communities.

The company is headquartered in Fort Worth, Texas.

Portfolio

SEGG Media’s operations are structured across three core verticals: Sports.com, Entertainment, and Lottery.com.

• Sports.com is SEGG’s global hub for immersive sports media, covering sim racing, football, motorsports, and athlete-led content. The vertical includes Sports.com Studios, Sports.com Media, and Nook, each focused on original storytelling and fan-driven experiences. In June 2025, SEGG announced plans to acquire a 51% stake in the sports and technology assets of GXR World to launch the Sports.com Super App, a first-of-its-kind platform combining live streaming, e-commerce, community chat, real-money and fantasy gaming, and sports news. Built on GXR’s tech stack, which already draws over one million monthly active users, the Super App is expected to debut in Q3 2025 with an initial focus on soccer and motorsports.
• The Entertainment pillar includes AI-driven event streaming, music and fashion media, and hybrid live experiences. As part of its acquisition-led growth model, SEGG is advancing a proposed deal to acquire DotCom Ventures Inc., owner of Concerts.com and TicketStub.com, to build out ticketing, event distribution, and direct-to-fan monetization infrastructure. This initiative aligns with SEGG’s five-year plan to unify content, commerce, and fan engagement under one platform, supported by a $100 million financing facility activated in May 2025.
• Lottery.com, SEGG’s ethical gaming division, delivers domestic and international lottery access, iGaming, instant wins, sports betting, charitable gaming through properties such as WinTogether, and syndicated results data to more than 800 publishers through Tinbu. With compliance issues resolved and new operating structures in place, the platform is being relaunched globally through Lottery.com International.

Together, these three verticals enable SEGG Media to unify fragmented fan experiences into a fully integrated global ecosystem—where sports, gaming, content, and commerce converge.

Market Opportunity

The global sports betting industry is undergoing rapid expansion as digital adoption accelerates and new markets open to regulation. According to Grand View Research, the sports betting market was valued at $100.9 billion in 2024 and is projected to reach $187.39 billion by 2030, growing at a compound annual growth rate of 11% from 2025 to 2030. This growth is fueled by increased internet penetration, widespread mobile usage, and rising interest in real-time, interactive fan experiences.

Beyond sports betting, SEGG Media also operates in the high-growth arenas of streaming, esports, and AI-powered content delivery. These adjacent markets are seeing double-digit global growth as fans demand more immersive, on-demand, and participatory forms of entertainment. With its diversified platform and strategic positioning across three converging verticals, SEGG Media is built to capitalize on multiple long-term secular trends and unlock scalable revenue opportunities.

Leadership Team

Matthew McGahan, Chief Executive Officer and Chairman, joined the company in October 2022. Since then, he has played a central role in stabilizing operations, restructuring the organization, and guiding its rebrand to SEGG Media. McGahan brings a mix of entrepreneurial drive and philanthropic leadership, having founded the UK-based charity Mask Our Heroes during the COVID-19 pandemic and previously built and sold the Harley-Davidson dealership Magic Automotive Group.

Tim Scoffham, CEO of Sports.com Media and Lottery.com International, brings over 20 years of leadership experience across gaming, media, and digital sports entertainment. Appointed following a successful consultancy period, Scoffham now leads SEGG’s global growth strategy for its iGaming and sports media divisions. He is focused on expanding international operations, aligning media and technology platforms, and driving revenue across high-growth jurisdictions while strengthening regulatory partnerships.

SEGG Media Corp. (NASDAQ: SEGG), closed Wednesday's trading session at $1.39, up 16.8067%, on 96,111 volume. The average volume for the last 3 months is 223,769 and the stock's 52-week low/high is $1.07/$26.45.

Recent News

• SEGG Media Corp. (NASDAQ: SEGG) - NetworkNewsBreaks - SEGG Media Corporation (NASDAQ: SEGG, LTRYW) Announces Leadership Changes as Board Appoints Robert Stubblefield Interim CEO
• InvestorNewsBreaks - SEGG Media Corporation (NASDAQ: SEGG, LTRYW) Surpasses 102 Million Views as Global Audience Momentum Accelerates
• Building Global Audience Through Live Competition: How SEGG Media Corporation (NASDAQ: SEGG) Is Scaling Sports Content and Female Motorsport Visibility